Success Metrics

Clinical Success Rate
92.3%

Based on 36 completed trials

Completion Rate
92%(36/39)
Active Trials
14(19%)
Results Posted
19%(7 trials)
Terminated
3(4%)

Phase Distribution

Ph phase_2
4
6%
Ph early_phase_1
1
1%
Ph not_applicable
64
89%
Ph phase_1
1
1%
Ph phase_4
1
1%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution71 total trials
Early Phase 1First-in-human
1(1.4%)
Phase 1Safety & dosage
1(1.4%)
Phase 2Efficacy & side effects
4(5.6%)
Phase 4Post-market surveillance
1(1.4%)
N/ANon-phased studies
64(90.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

36 of 42 finished

Non-Completion Rate

14.3%

6 ended early

Currently Active

14

trials recruiting

Total Trials

72

all time

Status Distribution
Active(18)
Completed(36)
Terminated(6)
Other(12)

Detailed Status

Completed36
unknown12
Recruiting8
Active, not recruiting6
Terminated3
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
72
Active
14
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.4%)
Phase 11 (1.4%)
Phase 24 (5.6%)
Phase 41 (1.4%)
N/A64 (90.1%)

Trials by Status

unknown1217%
terminated34%
enrolling_by_invitation23%
withdrawn34%
completed3650%
not_yet_recruiting23%
recruiting811%
active_not_recruiting68%

Recent Activity

Clinical Trials (72)

Showing 20 of 72 trialsScroll for more
NCT04027725Not Applicable

NEUROFEEDBACK TRAINING FOR OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT: A PILOT STUDY

Withdrawn
NCT04566900Not Applicable

Neurofeedback to Improve Working Memory in Mild Cognitive Impairment

Active Not Recruiting
NCT04560673Phase 2

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Active Not Recruiting
NCT07661888Not Applicable

Neurofeedback for Episodic Migraine

Not Yet Recruiting
NCT05472545Not Applicable

Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth

Completed
NCT04591314Not Applicable

Evaluation of the Effect of Neurofeedback Targeting EEG Theta / Beta Activities on the Strengthening of Wakefulness Maintenance Capacities and Cognitive Performance.

Completed
NCT05077072Phase 2

Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients

Active Not Recruiting
NCT07237412Not Applicable

Neurofeedback-based Visual Restoration Therapy

Recruiting
NCT05592600Not Applicable

Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults

Completed
NCT07085494Not Applicable

Neurofeedback and Cognitive Training for PBTS

Enrolling By Invitation
NCT07356661Not Applicable

Evaluation of the Efficacy of Neurofeedback Technique Based on EEG Desynchronization in Epileptic Patients

Not Yet Recruiting
NCT05669027Not Applicable

Mobile Neurofeedback for Low Back Pain

Recruiting
NCT07285681Not Applicable

Neurofeedback in Treatment of Attention Deficit Hyperactivity Disorder

Active Not Recruiting
NCT05732649Not Applicable

Improving Visual Perception and Visuo-motor Learning With Neurofeedback of Brain Network Interaction.

Completed
NCT04105868Not Applicable

Adolescent Attention to Emotion Study

Completed
NCT04446481Not Applicable

Neurofeedback to Aid Vets' Memory

Completed
NCT06188910Not Applicable

Neurofeedback and Nomophobia in Young Adults

Completed
NCT06240299Not Applicable

Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)

Recruiting
NCT05155787Not Applicable

Neurofeedback Training (NFT) on Sleep Quality and Cognitive Function Performance Among HIV-infected Persons

Completed
NCT04902339Not Applicable

Near-infrared Spectroscopy-based Neurofeedback as Adjunct to Mindfulness-Oriented Recovery Enhancement in Persons With Chronic Pain

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
72